Lazard Global Total Return and Income Fund, Inc. (NYSE:LGI – Get Free Report) was the target of a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 15,800 shares, a decline of 24.4% from the November 15th total of 20,900 shares. Based on an average trading volume of 52,300 shares, the short-interest ratio is currently 0.3 days.
Lazard Global Total Return and Income Fund Stock Down 0.2 %
Shares of LGI stock traded down $0.04 on Friday, hitting $16.53. 50,895 shares of the stock were exchanged, compared to its average volume of 45,363. The firm’s 50 day moving average is $17.00 and its two-hundred day moving average is $16.94. Lazard Global Total Return and Income Fund has a one year low of $14.84 and a one year high of $18.23.
Lazard Global Total Return and Income Fund Increases Dividend
The firm also recently declared a monthly dividend, which will be paid on Monday, December 23rd. Stockholders of record on Wednesday, December 11th will be given a $0.1494 dividend. The ex-dividend date of this dividend is Wednesday, December 11th. This represents a $1.79 annualized dividend and a dividend yield of 10.85%. This is a positive change from Lazard Global Total Return and Income Fund’s previous monthly dividend of $0.12.
Institutional Inflows and Outflows
Lazard Global Total Return and Income Fund Company Profile
Lazard Global Total Return and Income Fund, Inc is a closed ended balanced mutual fund launched and managed by Lazard Asset Management LLC. It invests in public equity and fixed income markets across the globe. The fund primarily invests in stocks of companies with market capitalization over $5 billion.
Featured Articles
- Five stocks we like better than Lazard Global Total Return and Income Fund
- Options Trading – Understanding Strike Price
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Expert Stock Trading Psychology Tips
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is the Nasdaq? Complete Overview with History
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Lazard Global Total Return and Income Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lazard Global Total Return and Income Fund and related companies with MarketBeat.com's FREE daily email newsletter.